Clinical Evaluation of Acuvue® 2 contact lenses in 7-Day Extended Wear - NI

Johnson and Johnson Vision Care Inc0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•A.Be between 18 and 39 years of age.
•B.Require a visual correction in both eyes (Monovision not allowed)
•C.Require a soft contact lens spherical correction between -0.50 and -5.75D in both eyes.
•D.Have an astigmatic correction less than 1.50D in both eyes.
•E.Be able to regularly wear the lenses on a 7 day/6 night extended wear basis (e.g. does not regularly swim more than once a week)
•F.Be correctable to a visual acuity of 20/30 or better in each eye with spherical distance correction.
•G.Have normal eyes with no evidence of abnormality or disease.

•A.Requires concurrent ocular medication.
•B.Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
•C.Clinically significant (Grade 3 or 4) slit lamp findings including corneal edema, corneal vascularization, corneal staining, tarsal abnormalities, bulbar injection, or any other abnormality of the cornea that would contraindicate contact lens wear.
•D.Is currently or has previously worn any hard PMMA or RGP contact lenses.

发起方

Johnson and Johnson Vision Care Inc